These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Skin findings of Staphylococcus aureus toxin-mediated infection in relation to toxin encoding genes. Courjon J; Hubiche T; Phan A; Tristan A; Bès M; Vandenesch F; Etienne J; Del Giudice P; Gillet Y Pediatr Infect Dis J; 2013 Jul; 32(7):727-30. PubMed ID: 23446443 [TBL] [Abstract][Full Text] [Related]
6. Purification of exfoliatin produced by Staphylococcus aureus of bacteriophage group 2 and its physicochemical properties. Kondo I; Sakurai S; Sarai Y Infect Immun; 1973 Aug; 8(2):156-64. PubMed ID: 4269383 [TBL] [Abstract][Full Text] [Related]
7. Staphylococcal scalded skin syndrome in an adult. Identification of exfoliative toxin A and B genes by polymerase chain reaction. Oono T; Kanzaki H; Yoshioka T; Arata J Dermatology; 1997; 195(3):268-70. PubMed ID: 9407177 [TBL] [Abstract][Full Text] [Related]
8. An inhibitor of Staphylococcus aureus exfoliative toxin. Al-Sulami AA; Al-Rubiay KK; Affat AM East Mediterr Health J; 2001; 7(1-2):121-7. PubMed ID: 12596961 [TBL] [Abstract][Full Text] [Related]
9. Staphylococcal Scalded Skin Syndrome Caused by a Rare Variant of Exfoliative-toxin-A+ S. aureus in an Adult Immunocompromised Woman. Saluzzo S; Layer F; Stingl G; Stary G Acta Derm Venereol; 2018 Jan; 98(1):138-139. PubMed ID: 28853493 [No Abstract] [Full Text] [Related]
10. Molecular typing of exfoliative toxin-producing Staphylococcus aureus strains involved in epidermolytic infections. Růzicková V; Pantůcek R; Petrás P; Doskar J; Sedlácek I; Rosypal S Int J Med Microbiol; 2003 Feb; 292(7-8):541-5. PubMed ID: 12635937 [TBL] [Abstract][Full Text] [Related]
11. Staphylococcal scalded skin syndrome. II. Serum level of anti exfoliatin and anti alpha-toxin in patients with staphylococcal scalded skin syndrome or bullous impetigo. Nishioka K; Nakano T; Hirao N; Teranishi H; Asada Y J Dermatol; 1977 Apr; 4(2):65-8. PubMed ID: 15461328 [TBL] [Abstract][Full Text] [Related]
12. [A case of staphylococcal scalded skin syndrome caused by exfoliative toxin-B producing MRSA]. Yokota S; Imagawa T; Katakura S; Mitsuda T; Arai K Kansenshogaku Zasshi; 1996 Feb; 70(2):206-10. PubMed ID: 8851394 [TBL] [Abstract][Full Text] [Related]
14. [Causative agent of impetigo: staphylococcal exfoliative toxin and regulation of the toxin production in Staphylococcus aureus]. Sakurai S Nihon Saikingaku Zasshi; 1996 Aug; 51(3):813-22. PubMed ID: 8840812 [No Abstract] [Full Text] [Related]
15. Two serotypes of exfoliatin and their distribution in staphylococcal strains isolated from patients with scalded skin syndrome. Kondo I; Sakurai S; Sarai Y; Futaki S J Clin Microbiol; 1975 May; 1(5):397-400. PubMed ID: 126250 [TBL] [Abstract][Full Text] [Related]
19. Staphylococcal exfoliative toxin B specifically cleaves desmoglein 1. Amagai M; Yamaguchi T; Hanakawa Y; Nishifuji K; Sugai M; Stanley JR J Invest Dermatol; 2002 May; 118(5):845-50. PubMed ID: 11982763 [TBL] [Abstract][Full Text] [Related]
20. New type of exfoliatin obtained from staphylococcal strains, belonging to phage groups other than group II, isolated from patients with impetigo and Ritter's disease. Kondo I; Sakurai S; Sarai Y Infect Immun; 1974 Oct; 10(4):851-61. PubMed ID: 4139120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]